Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Giskit MD is a medical technology company that develops AI-powered diagnostic support tools designed to enhance the precision of medical imaging analysis. The company's flagship product, Giskit Prostate, utilizes deep learning algorithms to assist radiologists in the detection and characterization of prostate cancer from MRI scans. By automating the identification of suspicious lesions and providing standardized reporting, Giskit MD aims to improve diagnostic accuracy and clinical workflows in oncology. The platform is designed to integrate seamlessly into existing hospital systems, supporting clinicians in making more informed treatment decisions. Giskit MD focuses on reducing the high rate of missed diagnoses and unnecessary biopsies associated with traditional prostate cancer screening methods.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Giskit MD.